Smith, Mark Alan,Claassen-Punt, Carine,Chen, Ling,Gershon, Ari Andrew
申请号：
AU2018238136
公开号：
AU2018238136A1
申请日:
2018.03.20
申请国别(地区):
AU
年份:
2019
代理人:
摘要：
The disclosure is directed to methods of treating schizophrenia or bipolar disorder by subcutaneously administering a sustained-release dosage form of olanzapine, or a pharmaceutically acceptable salt thereof. Methods of subcutaneously administering olanzapine, or a pharmaceutically acceptable salt thereof, are also described.
